GW Pharmaceuticals plc Files Registration Statement For NASDAQ Global Market Listing And U.S. Initial Public Offering

GW Pharmaceuticals plc announced that it has filed a registration statement with the U.S. Securities and Exchange Commission (the SEC) for an initial public offering of American Depositary Shares (ADSs) on the NASDAQ Global Market. GW has applied to have its ADSs quoted on the NASDAQ Global Market under the ticker symbol GWPH. The number of shares to be offered and the price range for the offering have not yet been determined. Lazard Capital Markets LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering. Canaccord Genuity is acting as co-lead manager and Roth Capital Partners is acting as co-manager.